Exemplis Discimus 2007, 151(1):47-52

Suspendisse pede lectus, iaculis id, pharetra et, porta non, leo.

Votino Barica, Killric Falensaranoa, Kangrang Reynoldsb, Shaka Zanea
a Institute of Sport Medicine, Teaching Hospital of Nar Shadda, Republic of Yavin
b 1st Clinic of Pathology, University of Castell, Republic of Mygeeto

Background: Proin nulla diam, commodo ac, cursus quis, ullamcorper et, diam. Vivamus rhoncus neque aliquam lectus pellentesque egestas. Morbi pede eros, laoreet in, varius vel, ultricies vitae, justo. Fusce pede lorem, lobortis ac, blandit sed, condimentum eget, est. Aenean lorem turpis, pretium in, congue eu, condimentum in, velit. Etiam nisl orci, facilisis sit amet, auctor sed, adipiscing eu, lorem. Quisque arcu velit, rhoncus a, cursus eget, cursus sed, metus. Ut mauris libero, vehicula commodo, imperdiet et, imperdiet eu, mauris.

Aim: Aenean mi metus, rutrum a, gravida eget, semper eget, risus. Ut lectus orci, ultricies id, ullamcorper lobortis, porttitor ac, dolor.

Methods: Quisque et lacus eget lectus volutpat commodo. Maecenas risus est, elementum ut, rhoncus ac, imperdiet et, lectus. Maecenas eros velit, placerat vel, aliquam in, interdum eget, ipsum. Duis non risus at quam fermentum scelerisque. Mauris odio libero, elementum ac, blandit id, tristique sit amet, dui. Sed magna felis, viverra in, pharetra at, sodales eu, ante. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Fusce lorem erat, ornare eget, tempus nec, imperdiet ac, magna.

Results: Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Fusce mattis, odio non condimentum semper, neque arcu tincidunt tellus, id sodales neque nunc quis leo.

Conclusion: Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Fusce odio nibh, eleifend id, egestas in, auctor ut, nibh. Praesent non metus ac nunc convallis faucibus. Vivamus neque diam, malesuada ut, pretium sed, hendrerit sed, lorem. Etiam elit nunc, ultricies in, lobortis nec, lacinia vel, felis.. Etiam diam neque, semper fringilla, ornare et, condimentum sit amet, erat. Fusce sem ligula, cursus ullamcorper, sagittis ac, egestas quis, diam. Quisque purus nisi, posuere vel, tristique vitae, consequat gravida, pede.

Keywords: Sed elit, Morbi at erat, Morbi cursus

Received: April 19, 2007; Accepted: May 10, 2007; Published: June 1, 2007 

Open full article

References

  1. Bibas R, Gaspar NK, Ramos-e-Silva M. Colchicine for dermatologic diseases. J Drugs Dermatol 2005; 4:196-204. Go to PubMed...
  2. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28:4859. Go to original source... Go to PubMed...
  3. Dvorak Z, Ulrichova J, Pichard-Garcia L, Modriansky M, Maurel P. Comparative eff ect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes. Toxicol In Vitro 2002; 16:21927. Go to original source... Go to PubMed...
  4. Jordan A, Hadfi eld JA, Lawrence NJ, McGown AT. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 1998; 18:25996. Go to original source... Go to PubMed...
  5. Sackett DL, Varma JK. Molecular mechanism of colchicine action: induced local unfolding of beta-tubulin. Biochemistry 1993; 32:135605. Go to original source... Go to PubMed...
  6. Modriansky M, Ulrichova J, Dvorak Z. Microtubules and commuting receptors. Letters in Drug Design & Discovery 2006; 3:567568. Go to original source... Go to PubMed...
  7. Dvorak Z, Vrzal R, Ulrichova J, Pascussi JM, Maurel P, Modriansky M. Involvement of Cytoskeleton in AhR-Dependent CYP1A1 Expression. Curr Drug Metab 2006; 7:3013. Go to original source... Go to PubMed...
  8. Dvorak Z, Ulrichova J, Modriansky M. Role of microtubules network in CYP genes expression. Curr Drug Metab 2005; 6:545 52. Go to original source... Go to PubMed...
  9. Kosina P, Dvorak Z, Walterova D. [The human hepatocyte: I. A model for studying metabolism and toxicity of xenobiotics]. Ceska Slov Farm 1999; 48:6571. Go to PubMed...
  10. Maurel P. The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Adv Drug Deliv Rev 1996; 22:105132. Go to original source...
  11. Husek A, Sutlupinar N, Sedmera P, Voegelein F, Valka I, Simanek V. Substances from Plants of the Subfamily Wurmbaeoideae and Their Derivatives.104. Alkaloids and Phenolics of Colchicum- Turcicum. Phytochemistry 1990; 29:30583060.
  12. Pichard L, Fabre I, Fabre G, Domergue J, Saint Aubert B, Mourad G, Maurel P. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 1990; 18:595606.
  13. Isom HC, Secott T, Georgoff I, Woodworth C, Mummaw J. Maintenance of diff erentiated rat hepatocytes in primary culture. Proc Natl Acad Sci U S A 1985; 82:32526. Go to original source... Go to PubMed...
  14. Dvorak Z, Kosina P, Walterova D, Simanek V, Bachleda P, Ulrichova J. Primary cultures of human hepatocytes as a tool in cytotoxicity studies: cell protection against model toxins by fl avonolignans obtained from Silybum marianum. Toxicol Lett 2003; 137:20112. Go to original source... Go to PubMed...
  15. Ulrichova J, Dvorak Z, Vicar J, Lata J, Smrzova J, Sedo A, Simanek V. Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaternary benzo[c]phenanthridine alkaloids. Toxicol Lett 2001; 125:12532. Go to original source... Go to PubMed...

Return to the content